In this article, we will look at the 5 Best Undervalued Stocks to Invest In Right Now. For a deeper discussion and an extended list, please see 12 Best Undervalued Stocks to Invest In Right Now.
5. QUALCOMM, Inc. (NASDAQ:QCOM)
QUALCOMM, Inc. (NASDAQ:QCOM) is one of the best undervalued stocks to invest in right now. QUALCOMM, Inc. (NASDAQ:QCOM) and T-Mobile announced on March 2 an expanded strategic collaboration to accelerate the wireless industry’s transition from 5G Advanced to 6G. With commercial deployments targeted beginning in 2029, the collaboration aligns with QUALCOMM, Inc.’s (NASDAQ:QCOM) broader 6G industry initiative, unveiled at MWC Barcelona 2026, to accelerate global readiness for the next generation of wireless innovation.
Management stated that the collaboration builds on a long history of joint innovation, with the two companies working together to shape the foundational technologies that will power 6G. T-Mobile is helping spearhead the industry’s path to 6G by ecosystem alignment, driving early research, and real-world validation of emerging capabilities.
The same day, QUALCOMM Inc. (NASDAQ:QCOM) and Siemens AG reported the showcasing of technology implementation at MWC Barcelona, aimed at accelerating autonomous factory production. The company reported that Qualcomm Technologies will be demonstrating on‑premise intelligence with AI integrated into a Siemens autonomous factory model. The two companies together exhibit the integration of private Industrial 5G connectivity with edge AI-based use-cases for more dynamic, efficient, and intelligent autonomous production.
QUALCOMM Inc. (NASDAQ:QCOM) develops and commercializes foundational technologies for the wireless industry, including 3G, 4G, and 5G wireless connectivity and high-performance and low-power computing, including on-device AI. The company operates across various high-growth markets, including autonomous vehicles and smartphones. QUALCOMM’s Snapdragon augmented reality technology is the next generation of mobile computing.
4. Blackstone Inc. (NYSE:BX)
Blackstone Inc. (NYSE:BX) is one of the best undervalued stocks to invest in right now. Barclays cut the price target on Blackstone Inc. (NYSE:BX) to $126 from $164 on March 2, maintaining an Equal Weight rating on the shares while revising estimates across the alternative asset manager group. The firm told investors that while it is too early to determine the real AI impact on portfolio companies, it lowered business development company-related earnings on lower flow assumptions and realization.
In another development, Blackstone Inc. (NYSE:BX) reported on February 23 that Blackstone Life Sciences (BXLS) announced a research and development funding agreement to advance the clinical development of bleximenib, which is an investigational oral menin inhibitor, for acute myeloid leukemia (AML). Management stated that despite AML being the most common type of acute leukemia in adults, it continues to be an extremely challenging ailment to treat and has the lowest survival of all leukemia types.
Blackstone Inc. (NYSE:BX) further reported that Johnson & Johnson and funds managed by BXLS would jointly finance a portion of the ongoing and future clinical trials of bleximenib in AML. The agreement marks the first time that BXLS and Johnson & Johnson have entered into a co-funding agreement.
Blackstone Inc. (NYSE:BX) provides investment and fund management services. The company operates through the following segments: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions.
3. AbbVie Inc. (NYSE:ABBV)
AbbVie Inc. (NYSE:ABBV) is one of the best undervalued stocks to invest in right now. AbbVie Inc. (NYSE:ABBV) announced on March 2 positive topline results from the Phase 3, randomized, placebo-controlled, double-blind AFFIRM study evaluating the efficacy and safety of risankizumab subcutaneous induction treatment versus placebo in adult patients with moderately to severely active Crohn’s disease. The company reported that results from the study show notably higher proportions of patients treated with risankizumab SC induction attained the co-primary endpoints of Crohn’s Disease Activity Index clinical remission and endoscopic response at week 12 compared to placebo.
Kori Wallace, M.D., Ph.D., vice president, global head of immunology clinical development, AbbVie Inc. (NYSE:ABBV), stated that the level of endoscopic response marks a particularly meaningful achievement for Crohn’s disease patients, and that these results highlight the company’s continued innovation and research to raise the standard of care.
The company further reported that during the 12-week, double-blind, placebo-controlled period, the safety profile of risankizumab SC remained consistent with the safety profile observed in Crohn’s disease, with no new safety risks observed. Upper respiratory tract infection, abdominal pain, and arthralgia were the most common adverse events observed among patients receiving risankizumab, and serious adverse events occurred in 0.5% of patients in the risankizumab SC group compared to 3.1% in the placebo group.
AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology, and various other serious health conditions.
2. Salesforce, Inc. (NYSE:CRM)
Salesforce, Inc. (NYSE:CRM) is one of the best undervalued stocks to invest in right now. Salesforce, Inc. (NYSE:CRM) and Formula 1 announced on March 3 the launch of a new fan companion agent to scale and personalize engagement for F1’s 827 million global fans. Management stated that the new agent is developed as part of the multi-year partnership extension between Salesforce, Inc. (NYSE:CRM) and Formula 1, and will initially be available on F1.com, acting as a pivotal tool to provide fans with 24/7 education on the new 2026 regulations. The Agentforce-powered companion will offer clear and accessible responses to queries regarding the updated technical regulations by drawing on trusted F1 sources, and will also monitor trending questions and themes to provide fans with valuable insights.
Management stated that this marks the next phase of F1’s Agentforce 360 deployment across its digital ecosystem, with the organization continuing its transformation into an Agentic Enterprise. In a separate development, Citi lifted the price target on Salesforce, Inc. (NYSE:CRM) to $200 from $197 on March 2, keeping a Neutral rating on the shares and updating the company’s model post the earnings report.
Salesforce, Inc. (NYSE:CRM) designs and develops cloud-based enterprise software for customer relationship management. Its solutions encompass customer service and support, sales force automation, digital commerce, marketing automation, collaboration, community management, industry-specific solutions, and Salesforce platforms. It also offers training, guidance, support, and advisory services.
1. Micron Technology, Inc. (NASDAQ:MU)
Micron Technology, Inc. (NASDAQ:MU) is one of the best undervalued stocks to invest in right now. On March 4, Aletheia lifted the price target on Micron Technology, Inc. (NASDAQ:MU) to $650 from $315, maintaining a Buy rating on the shares and telling investors that the surge in demand for AI training and inference is continually driving massive consumption of HBM, while the rapid emergence of agentic AI workloads “requires equally large volume (if not more) of diversified memories”. The firm doubled the FY26 EPS estimates and tripled its FY27 estimates.
Goldman Sachs also raised the price target on Micron Technology, Inc. (NASDAQ:MU) to $360 from $235 on March 3, maintaining a Neutral rating on the shares. The same day, Micron Technology, Inc. (NASDAQ:MU) announced that it extended its leadership in low-power server memory by shipping customer samples of the industry’s highest-capacity LPDRAM module: 256GB SOCAMM2. It stated that the milestone marks a transformation step forward for AI data centers, enabled by the industry’s first monolithic 32Gb LPDDR5X design and delivering low-power memory capacity that can unlock new system architectures.
Micron Technology, Inc. (NASDAQ:MU) provides innovative memory and storage solutions. Its operations are divided into the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU).
While we acknowledge the potential of MU to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MU and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
